Who Owns Drugs Made In America Acquisition Stock?
NASDAQ: DMAAFinancial ServicesShell CompaniesUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 53.43%
- Held by insiders
- 23.57%
- Institutional holders
- 29
- Institutions 53.4%
- Insiders 23.6%
- Public and other 23.0%
Who owns Drugs Made In America Acquisition stock?
Institutional investors own about 53.4% of Drugs Made In America Acquisition's shares, spread across 29 institutions that file 13F reports. That level of institutional ownership is moderate. Insiders, including executives, directors and large founding shareholders, hold 23.57% of DMAA.
The largest institutional holders are Karpus Management, Inc. (10.33%), Mizuho Securities USA LLC (8.52%) and Polar Asset Management Partners Inc. (4.72%). Together, the top 10 institutions control 44.3% of shares outstanding. In their latest filings, 2 of the top 10 institutions increased their DMAA positions and 8 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of DMAA
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Karpus Management, Inc. | 2.51M | 10.33% | -0.9% |
| Mizuho Securities USA LLC | 2.07M | 8.52% | +3.5% |
| Polar Asset Management Partners Inc. | 1.15M | 4.72% | -28.4% |
| Glazer Capital LLC | 999.90K | 4.12% | -40.4% |
| Wolverine Asset Management, LLC | 832.09K | 3.43% | -46.4% |
| Highbridge Capital Management, LLC. | 809.05K | 3.33% | -38.9% |
| First Trust Capital Management L.P. | 786.46K | 3.24% | -64.9% |
| Heights Capital Management, Inc | 648.08K | 2.67% | -0.3% |
| Westchester Capital Management, LLC | 581.79K | 2.40% | -65.1% |
| Clear Street Group Inc. | 382.44K | 1.58% | +8.0% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of DMAA
| Fund | Shares | % Held |
|---|---|---|
| INVESTMENT MANAGERS SERIES TRUST II-First Trust Merger Arbitrage Fund | 675.37K | 2.78% |
| Merger Fund-The Merger Fund | 564.80K | 2.33% |
| INVESTMENT MANAGERS SERIES TRUST II-First Trust Multi-Strategy Fund | 105.08K | 0.43% |
| Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund | 62.27K | 0.26% |
| JNL Series Trust-JNL Multi-Manager Alternative Fund | 10.28K | 0.04% |
| Virtus Event Opportunities Trust-Virtus Westchester Credit Event Fund | 6.71K | 0.03% |
Frequently asked questions
Who is the largest shareholder of Drugs Made In America Acquisition?
Karpus Management, Inc. is the largest institutional shareholder of DMAA, owning 10.33% of shares outstanding (2.51M shares) as of its latest 13F filing.
What percentage of Drugs Made In America Acquisition is owned by institutions?
Institutions own about 53.4% of DMAA shares and 69.9% of the public float.
How much of Drugs Made In America Acquisition do insiders own?
Insiders, such as officers and directors, own about 23.57% of DMAA shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.